MG

Manju Gupta

Active Director Director DIN 09528266
DIN 09528266 First appointment Mar 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Manju Gupta

Data last updated:

Manju Gupta is a Director at Ruination Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Ruination Pharmaceutical Private Limited reported revenue of ₹2 Lakh (FY 2024).

DIN 09528266
Primary Designation Director
Industry Pharma
First Appointment 07 Mar 2022
Oldest Company Age 4 yrs
Largest company Ruination Pharmaceutical Private Limited · ₹2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Mar 20222022₹2 Lakh (FY 2024)Active

Board colleagues of Manju Gupta

NameDINCompanyDesignation
Madhuri09528265Ruination Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ruination Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Manju Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Gupta

Manju Gupta currently holds 1 directorship: Ruination Pharmaceutical Private Limited (Director, since 07 Mar 2022, revenue ₹2 Lakh (FY 2024)).

Manju Gupta was first appointed on 07 Mar 2022 as Director at Ruination Pharmaceutical Private Limited.

The current boards of Manju Gupta's companies include Madhuri (Ruination Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available